Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ RFX4 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA562205
Description
Immunogen sequence: STTGAMQSYT WSLTYTVTTA AGSPAENSQQ LPCMRNTHVP SSSVTHRIPV YPHREEHGYT GSYNYGSYGN QHPHPMQSQY PALPH Highest antigen sequence identity to the following orthologs: Mouse - 93%, Rat - 95%.
This gene is a member of the regulatory factor X gene family, which encodes transcription factors that contain a highly-conserved winged helix DNA binding domain. The protein encoded by this gene is structurally related to regulatory factors X1, X2, X3, and X5. It has been shown to interact with itself as well as with regulatory factors X2 and X3, but it does not interact with regulatory factor X1. This protein may be a transcriptional repressor rather than a transcriptional activator. Three transcript variants encoding different isoforms have been described for this gene.
Specifications
RFX4 | |
Polyclonal | |
Unconjugated | |
RFX4 | |
4933412G19Rik; NYD-sp10; Regulatory factor X 4; regulatory factor X 4 protein; regulatory factor X, 4 (influences HLA class II expression); regulatory factor X4; RFX4; RGD1562092; Testis development protein NYD-SP10; transcription factor RFX4; winged-helix transcription factor RFX4 | |
Rabbit | |
Antigen Affinity Chromatography | |
RUO | |
5992 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin), Immunocytochemistry | |
0.2 mg/mL | |
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
Q33E94 | |
RFX4 | |
Recombinant protein corresponding to Human RFX4. Recombinant protein control fragment (Product #RP-101198). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction